Table 2.
Overview of enrollment, intervention, and assessments in the 3for1-project across measurement points
| STUDY PERIOD | ||||||
|---|---|---|---|---|---|---|
| Enrollment | Baseline | Exit | Follow-up | |||
| TIMEPOINT* | t0 | t0 | 6 months | t1 | t2 | 24 months |
| ENROLLMENT: | ||||||
| Eligibility screen (incl. psychological distress) | X | |||||
| Project information | X | |||||
| Informed consent | X | |||||
| Allocation** | X | |||||
| INTERVENTIONS: | ||||||
| 3for1 components | X | X | X | |||
| Control group | X | X | X | |||
| ASSESSMENTS: | ||||||
| Questionnaires: | ||||||
| Sociodemographic variables | X | X | X | |||
| Motivation to work | X | X | X | |||
| Job-search self-efficacy (JSSE) | X | X | X | |||
| Psychological distress (K6) | X | X | ||||
| Health-related quality of life (EQ-5D) | X | X | X | |||
| General health state (EQ-VAS) | X | X | X | |||
| General well-being (WHO-5) | X | X | X | |||
| Somatic symptom burden (SSS-8) | X | X | X | |||
| Depressive symptoms (PHQ-9) | X | X | X | |||
| Symptoms of anxiety (GAD-7) | X | X | X | |||
| Mental health diagnoses | X | X | X | |||
| Mental health treatment | X | X | X | |||
| Social outcomes (SIX) | X | X | X | |||
| Social inclusion (ESIS) | X | X | X | |||
| Help-seeking (GHSQ; AHSQ) | X | X | X | |||
| Self-stigma (SSMIS-SF) | X | X | X | |||
| Intervention evaluation (IG only) | X | |||||
| Structured interviews: | ||||||
| Sociodemographic variables / changes in these variables | X | X | X | |||
| (Un-) Employment history | X | |||||
| Current/recent employment | X | X | ||||
| Attempts on re-employment | X | X | X | |||
| Barriers to re-employment | X | |||||
| Mental health issues & treatment | X | X | X | |||
| Health service utilization | X | X | X | X | ||
| Job center records: | ||||||
| Receiving benefits: yes vs. no | X | X | X | |||
| Duration of receiving benefits after study entry (in months) | X | X | X | |||
| Database records (IG only): | ||||||
| Intervention utilization intensity (in minutes) | X | |||||
| Intervention component utilization intensity (in minutes) | X | |||||
*t0: Enrollment and baseline assessment at the same timepoint, individual intervention period of 12 months for IG starting directly afterward; t1: exit interview and questionnaires 12 months after enrollment and baseline, and, for IG, directly after end of intervention period; t2: follow-up interview and questionnaires 18 months after enrollment and baseline, and, for IG, 6 months after end of intervention period
**Allocation based on enrollment timing in study: allocation of the first cohort to CG and the second cohort to IG